首页> Annals of oncology : official journal of the European Society for Medical Oncology> Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies.

Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies.

导出原文传递

翻译打印收藏纠错

第一作者： F,Marmorino

第一单位： Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa.

作者： F,Marmorino ^[1] ; D,Rossini ^[1] ; S,Lonardi ^[2] ; R,Moretto ^[1] ; G,Zucchelli ^[1] ; G,Aprile ^[3] ; E,Dell'Aquila ^[4] ; M,Ratti ^[5] ; F,Bergamo ^[2] ; G,Masi ^[1] ; F,Urbano ^[6] ; M,Ronzoni ^[7] ; M,Libertini ^[8] ; B,Borelli ^[1] ; G,Randon ^[9] ; A,Buonadonna ^[10] ; G,Allegrini ^[11] ; N,Pella ^[12] ; V,Ricci ^[13] ; A,Boccaccino ^[1] ; T P,Latiano ^[14] ; S,Cordio ^[15] ; A,Passardi ^[16] ; E,Tamburini ^[17] ; L,Boni ^[18] ; A,Falcone ^[1] ; C,Cremolini ^[19]

作者单位： Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa. ^[1] Department of Clinical and Experimental Oncology, Medical Oncology Unit 1, Veneto Institute of Oncology - IRCCS, Padova. ^[2] Department of Oncology, General and University Hospital, Udine; Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza. ^[3] Department of Medical Oncology, Campus Biomedico University, Roma. ^[4] Oncology Department, Oncology Unit, ASST of Cremona, Cremona. ^[5] Department of Radiological Science, Oncology and Pathology, Policlinico Umberto I, "Sapienza" University of Rome, Roma. ^[6] Department of Oncology, Istituto Scientifico San Raffaele IRCSS, Milano. ^[7] Medical Oncology Unit, Poliambulanza Foundation, Brescia. ^[8] Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. ^[9] Department of Medical Oncology, IRCCS CRO National Cancer Institute, Aviano. ^[10] Department of Medical Oncology, Unit of Medical Oncology, Livorno Hospital, Azienda Toscana Nord Ovest, Livorno. ^[11] Department of Oncology, General and University Hospital, Udine. ^[12] Department of Oncology, S. Croce and Carle Teaching Hospital, Cuneo. ^[13] Oncology Unit, Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo. ^[14] Medical Oncology Unit, ARNAS Garibaldi Catania, Catania. ^[15] Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola. ^[16] Department of Medical Oncology, Card. G. Panico Hospital of Tricase, Tricase. ^[17] Clinical Trials Coordinating Center, Toscano Cancer Institute, University Hospital Careggi, Firenze, Italy. ^[18] Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, Pisa. Electronic address: chiaracremolini@gmail.com. ^[19]

关键词 FOLFOXIRI/bevacizumab age gender metastatic colorectal cancer